SHEN211 Tablets

· JKT Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHEN211 Tablets, covering 2024-03-04 to 2024-03-04. Get the full timeline:

Most recent: Clinical Trial Update: SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19) [Phase 2]